Suppr超能文献

血清和血清白蛋白抑制中性粒细胞胞外诱捕网(NETs)的形成。

Serum and Serum Albumin Inhibit Formation of Neutrophil Extracellular Traps (NETs).

机构信息

Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.

Institute of Physical Chemistry, University of Göttingen, Göttingen, Germany.

出版信息

Front Immunol. 2019 Jan 24;10:12. doi: 10.3389/fimmu.2019.00012. eCollection 2019.

Abstract

The formation of neutrophil extracellular traps (NETs) is an immune defense mechanism of neutrophilic granulocytes. Moreover, it is also involved in the pathogenesis of autoimmune, inflammatory, and neoplastic diseases. For that reason, the process of NET formation (NETosis) is subject of intense ongoing research. approaches to quantify NET formation are commonly used and involve neutrophil stimulation with various activators such as phorbol 12-myristate 13-acetate (PMA), lipopolysaccharides (LPS), or calcium ionophores (CaI). However, the experimental conditions of these experiments, particularly the media and media supplements employed by different research groups, vary considerably, rendering comparisons of results difficult. Here, we present the first standardized investigation of the influence of different media supplements on NET formation . The addition of heat-inactivated (hi) fetal calf serum (FCS), 0.5% human serum albumin (HSA), or 0.5% bovine serum albumin (BSA) efficiently prevented NET formation of human neutrophils following stimulation with LPS and CaI, but not after stimulation with PMA. Thus, serum components such as HSA, BSA and hiFCS (at concentrations typically found in the literature) inhibit NET formation to different degrees, depending on the NETosis inducer used. In contrast, in murine neutrophils, NETosis was inhibited by FCS and BSA, regardless of the inducer employed. This shows that mouse and human neutrophils have different susceptibilities toward the inhibition of NETosis by albumin or serum components. Furthermore, we provide experimental evidence that albumin inhibits NETosis by scavenging activators such as LPS. We also put our results into the context of media supplements most commonly used in NET research. In experiments with human neutrophils, either FCS (0.5-10%), heat-inactivated (hiFCS, 0.1-10%) or human serum albumin (HSA, 0.05-2%) was commonly added to the medium. For murine neutrophils, serum-free medium was used in most cases for stimulation with LPS and CaI, reflecting the different sensitivities of human and murine neutrophils to media supplements. Thus, the choice of media supplements greatly determines the outcome of experiments on NET-formation, which must be taken into account in NETosis research.

摘要

中性粒细胞胞外诱捕网(NETs)的形成是中性粒细胞的一种免疫防御机制。此外,它也参与自身免疫、炎症和肿瘤疾病的发病机制。因此,NET 形成(NETosis)的过程是当前研究的热点。目前常用的定量 NET 形成的方法涉及用各种激活剂(如佛波醇 12-肉豆蔻酸 13-乙酸酯(PMA)、脂多糖(LPS)或钙离子载体(CaI))刺激中性粒细胞。然而,这些实验的实验条件,特别是不同研究小组使用的培养基和培养基补充剂,差异很大,使得结果的比较变得困难。在这里,我们首次对不同培养基补充剂对 NET 形成的影响进行了标准化研究。添加热灭活(hi)胎牛血清(FCS)、0.5%人血清白蛋白(HSA)或 0.5%牛血清白蛋白(BSA)可有效阻止 LPS 和 CaI 刺激后的人中性粒细胞 NET 形成,但不能阻止 PMA 刺激后的 NET 形成。因此,HSA、BSA 和 hiFCS 等血清成分(在文献中通常发现的浓度)在不同程度上抑制 NET 形成,这取决于所使用的 NETosis 诱导剂。相比之下,在小鼠中性粒细胞中,无论使用哪种诱导剂,FCS 和 BSA 均抑制 NET 形成。这表明,小鼠和人中性粒细胞对白蛋白或血清成分抑制 NETosis 的敏感性不同。此外,我们提供了实验证据表明,白蛋白通过清除 LPS 等激活剂来抑制 NETosis。我们还将结果置于 NET 研究中最常用的培养基补充剂的背景下。在人中性粒细胞实验中,培养基中通常添加 FCS(0.5-10%)、热灭活(hiFCS,0.1-10%)或人血清白蛋白(HSA,0.05-2%)。对于小鼠中性粒细胞,大多数情况下在 LPS 和 CaI 刺激时使用无血清培养基,这反映了人中性粒细胞和小鼠中性粒细胞对培养基补充剂的敏感性不同。因此,培养基补充剂的选择极大地决定了 NET 形成实验的结果,这在 NETosis 研究中必须考虑到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ee5/6354573/57786a924466/fimmu-10-00012-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验